BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 30715139)

  • 41. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
    Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
    Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup.
    Vittoria L; Sala L; Summo V; Capone I; Conca E; Toma M; Ottolenghi J; Testa F; Cortinovis U; Paolini B; Cabras A; Aiello A; Bozzi F
    Tumori; 2023 Oct; 109(5):458-465. PubMed ID: 36942354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 26 Years of Textured Implants and BIA-ALCL: Continued Vigilance and Counseling Are Warranted.
    Dabic S; McCarthy CM; Matros E; Disa JJ; Mehrara BJ; Nelson JA
    Plast Reconstr Surg; 2021 Sep; 148(3):517e-518e. PubMed ID: 34346912
    [No Abstract]   [Full Text] [Related]  

  • 44. New insights into breast implant-associated anaplastic large cell lymphoma.
    Laurent C; Haioun C; Brousset P; Gaulard P
    Curr Opin Oncol; 2018 Sep; 30(5):292-300. PubMed ID: 30096095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Review of Epidemiology and Prevalence Assessment in Europe.
    Santanelli di Pompeo F; Sorotos M; Clemens MW; Firmani G;
    Aesthet Surg J; 2021 Aug; 41(9):1014-1025. PubMed ID: 33022037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Influence of BIA-ALCL on the Use of Textured Breast Implant and its Placement: A Survey of Dutch Plastic Surgeons.
    Bletsis PP; van Veen MM; van der Lei B
    Aesthet Surg J; 2023 Jul; 43(8):NP595-NP601. PubMed ID: 36929763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in the United States: A Systematic Review.
    Santanelli di Pompeo F; Clemens MW; Paolini G; Firmani G; Panagiotakos D; Sorotos M
    Aesthet Surg J; 2023 Dec; 44(1):NP32-NP40. PubMed ID: 37616552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.
    Nelson JA; Dabic S; Mehrara BJ; Cordeiro PG; Disa JJ; Pusic AL; Matros E; Dayan JH; Allen RJ; Coriddi M; Polanco TO; Shamsunder MG; Wiser I; Morrow M; Dogan A; Cavalli MR; Encarnacion E; Lee ME; McCarthy CM
    Ann Surg; 2020 Sep; 272(3):403-409. PubMed ID: 32694446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What's Your Micromort? A Patient-Oriented Analysis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Sieber DA; Adams WP
    Aesthet Surg J; 2017 Sep; 37(8):887-891. PubMed ID: 29036945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018.
    McCarthy CM; Loyo-BerrĂ­os N; Qureshi AA; Mullen E; Gordillo G; Pusic AL; Ashar BS; Sommers K; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):65S-73S. PubMed ID: 30817558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
    Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
    Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Oishi N; Miranda RN; Feldman AL
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia: A Longitudinal Study of Implant and Other Related Risk Factors.
    Loch-Wilkinson A; Beath KJ; Magnusson MR; Cooter R; Shaw K; French J; Vickery K; Prince HM; Deva AK
    Aesthet Surg J; 2020 Jul; 40(8):838-846. PubMed ID: 31738381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient.
    Kim IK; Hong KY; Lee CK; Choi BG; Shin H; Lee JH; Kim MK; Gu MJ; Choi JE; Kim TG
    Aesthet Surg J; 2021 Apr; 41(5):NP214-NP222. PubMed ID: 33367520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Dutch Breast Implant Registry: Registration of Breast Implant-Associated Anaplastic Large Cell Lymphoma-A Proof of Concept.
    Becherer BE; de Boer M; Spronk PER; Bruggink AH; de Boer JP; van Leeuwen FE; Mureau MAM; van der Hulst RRJW; de Jong D; Rakhorst HA
    Plast Reconstr Surg; 2019 May; 143(5):1298-1306. PubMed ID: 31033810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.
    Naga HI; Mellia JA; Basta MN; Morris MP; Christopher AN; Campbell FM; Sommers K; Levinson H; Nelson JA; Fischer JP
    Plast Reconstr Surg; 2022 Oct; 150(4):762-769. PubMed ID: 35862104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
    Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
    Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is Breast Implant Associated-Anaplastic Large Cell Lymphoma linked to textured implants?
    Nava MB; Chiodini P; Catanuto G; Rocco N
    Aesthetic Plast Surg; 2021 Dec; 45(6):2593-2601. PubMed ID: 33837459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
    D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
    Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.